| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.3 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.3 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |